Iterum Therapeutics sets terms of IPO, to raise up to $85 million
Iterum Therapeutics set terms Tuesday for its initial public offering, in which the drugmaker could raise up to $85.3 million. The company, which is developing sulope.....»»
ADC Therapeutics sets IPO terms to raise up to $185.3 million
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
ADC Therapeutics sets IPO terms, to be valued at up to $1 billion
ADC Therapeutics S.A. set terms of its initial public offering, as the Switzerland-based biotechnology company focused on cancer treatments looks to raise up to $185.3 million. ADC is offering 10,295,000 shares in the IPO, which is.....»»
Keros Therapeutics sets IPO terms, expects to raise up to $80 million
Keros Therapeutics has set terms of its initial public offering, in which it expects to raise up to $80 million, and be valued at about $291 million. The biopharmaceutical company, which is developing.....»»
Black Diamond Therapeutics sets IPO terms, to raise up to $160.2 million
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Karuna Therapeutics sets IPO terms, to be valued at up to $363 million
Karuna Therapeutics Inc. set terms Monday for its initial public offering, in which the biopharmaceutical company developing treatments for neuropsychiatric conditions is expected to raise up to $74.4 mil.....»»
Dermavant sets IPO terms, which would value the company at $343.6 million
Dermavant Sciences Ltd. set terms Monday of its initial public offering, as it looks to raise $107.8 million. The biopharmaceutical company developing therapeutics in medical dermatology said it was offering 7.7 million shares in the IPO, which is expect.....»»
Rubius Therapeutics sets terms of IPO, which could value the company at up to $1.7 billion
Rubius Therapeutics set terms of its initial public offering, which is expected to raise up to $209.7 million. The company, which develops red blood cellular therapies, said it is offering 9.53 million shares in its IPO, which is expec.....»»
Singular Genomics sets IPO terms, to raise up to $187 million and be valued at up to $1.5 billion
Singu.....»»
Kaltura sets IPO terms, to raise up to $278.4 million
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Design Therapeutics sets IPO terms, to raise up to $240 mln
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Zhihu sets IPO terms, as the Hong Kong-based online community looks to raise up to $633 million
Zhihu Inc. has set terms of its initial public offering in the U.S., as the Hong Kong-based Q&A-inspired online content community looks to raise up to $632.5 million. The company is offering 55 million American depositary shares, representing 27.5 milli.....»»
VIZIO Holding sets terms for IPO, as it looks to raise up to $174 million and be valued at $4.2 billion
VIZIO Holding Corp. disclosed Tuesday that the terms of its initi.....»»
DigitalOcean sets IPO terms, to be valued at nearly $5 billion
DigitalOcean Holdings Inc. disclosed Monday that it set terms of its initial public offering, as the New York-based cloud computing company looks to raise up to $775.5 million and be valued at up to $4.95 billion. The company is offering 16.5 million sh.....»»
Telus International sets IPO terms, to be valued at up to $5.6 billion
Telus International Inc. has set terms for its initial public offering, in which the Canada-based telecommunications company looks to raise up to about $548.2 million. The company is offerin.....»»
SelectQuote sets IPO terms, could be valued at up to $3.1 billion
SelectQuote set terms for its initial public offering, as the online insurance broker looks to raise up to $475 million. The company is offering 25 million share in the IPO, which is expected to price between $17 and $19 a share. With 162.65 mil.....»»
ADC Therapeutics to offer 7.36 million shares in IPO, priced at $16 to $18 each
ADC Therapeutics Inc. amended the terms for its planned initial public offering on Monday, with plans to offer 7.36 million shares priced at $16 to $18 each. The Swiss company would raise $132.58 million at the top of that range. It has applied.....»»
Keros Therapeutics sets IPO terms to raise up to $80 mln
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Zentalis Pharmaceuticals sets IPO terms, to be valued at up to $592 million
Zentalis Pharmaceuticals set terms of its initial public offering, in which the biopharmaceutical company developing cancer treatments is expected to raise up to $137.7 million. Zentalis is offering.....»»
Imara sets IPO terms, expects to raise up to $80 million and be valued at up to $294 million
Imara Inc. set terms of its initial public offering, in which the biopharmaceutical company could raise up to $80.1 million, and be valued .....»»
Beam Therapeutics to offer 6.25 million shares in planned IPO priced at $15 to $17 each
Beam Therapeutics Inc. set terms for its planned initial public offering on Monday, saying in a regulatory filing that it plans to offer 6.25 million shares priced at $15 to $17 each. The developer of gene editing technology would raise $106......»»